Topic:Evaluation of a short term topical interferon a-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia
EDUCATIONAL OBJECTIVES: BY THE END OF THE ACTIVITY, PARTICIPANTS WILL BE ABLE TO:
1. Review current literature in Ophthalmology and related fields to narrow the gap between what is in
literature and our daily practice.
2. Change practice patterns that are not consistent with current standards of care.
3. Promote interdisciplinary learning between general Ophthalmologists and sub-specialists (Cornea,
Retina, Neuro-Ophthalmology, Oculoplastic, Glaucoma, Pediatrics).
4. Possible language barriers in some patient encounters will be discussed and addressed, along with possible cultural disparities.
Target Audience: Physician Focus: Opthalmology physicians and sub-specialists (Cornea, Retina, Neuro-Ophthalmology, Oculoplastic,Glaucoma, Pediatrics)
Planner: Lydia Hsu, MD, Opthalmology, KP RWC
Speakers: Jennifer Rose-Nussbaumber, MD, KP RWC
Resources: See session article
Disclosure: The presenters and program planners of this conference have disclosed that he/she has no relevant financial relationships with commercial interest. The CME Department has reviewed their disclosure information for the planner(s) and/or committee / faculty for this program and they do not have relationships that present a conflict of interest.
Kaiser Permanente Medical Center - Redwood City takes responsibility for the content , quality and scientific integrity of this CME Activity .
Kaiser Permanente does not endorse any brand -name products.
Accreditation and Credits
The Kaiser Permanente Medical Center - Redwood City is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
The Kaiser Permanente Medical Center - Redwood City designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
- 1.00 AMA PRA Category 1 Credit(s)™